Table 3 Difference in antipsychotic prescribing measure to Medicaid-enrolled youth, 2019 vs. 2021
| Â | Received a Report Card (n=64) | Did Not Receive a Report Card (n=143) | ||||
|---|---|---|---|---|---|---|
2019 | 2021 | p-value | 2019 | 2021 | p-value | |
1: Share of youth with at least 1 antipsychotic prescription fill | 34% | 34% | p=0.9812 | 29% | 30% | p=0.7853 |
2: Share of youth with at least 1 antipsychotic prescription fill who are ages 5-14 | 70% | 60% | p=0.0171 | 67% | 57% | p=0.0302 |
3: Share of youth with at least 1 antipsychotic prescription fill and polypharmacy (3 or more drug classes) for 90+ days in that year | 14% | 10% | p=0.0160 | 14% | 11% | p=0.2637 |
4: Share of youth with 2 antipsychotics concurrently for 90+ days in that year | 2% | 4% | p=0.3154 | 2% | 4% | p=0.1517 |
5: Share of youth with at least 1 antipsychotic prescription fill who did not have a prior authorization approved diagnosis in that year | 21% | 28% | p=0.0320 | 28% | 43% | p=0.0006 |
6: Share of youth with at least 1 antipsychotic prescription fill who did not receive appropriate lipids and glucose testing in that year | 57% | 49% | p=0.0554 | 52% | 55% | p=0.4351 |
7: Share of youth with at least 1 antipsychotic prescription fill who did not receive other behavioral health outpatient services in that year | 16% | 20% | p=0.3590 | 23% | 36% | p=0.0053 |
8: Share of youth with at least 1 antipsychotic prescription fill who did not receive behavioral health outpatient services prior to their index antipsychotic prescription | 30% | 33% | p=0.5726 | 37% | 43% | p=0.7802 |
Number of youth with at least 1 antipsychotic prescription fill | 960 | 628 | Â | 496 | 506 | Â |